Featured Research

from universities, journals, and other organizations

Manufacturing facilities release pharmaceuticals to the environment, USGS study finds

Date:
June 7, 2010
Source:
United States Geological Survey
Summary:
Pharmaceutical manufacturing facilities can be a significant source of pharmaceuticals to surface waters, according to a new study by the US Geological Survey and the State of New York. Outflow from two wastewater treatment plants in New York that receive more than 20 percent of their wastewater from pharmaceutical facilities had concentrations of pharmaceuticals that were 10 to 1,000 times higher than outflows from 24 plants nationwide that do not receive wastewater from pharmaceutical manufacturers.

U.S. Geological Survey hydrologic technicians collect a stream sample from Hallocks Mill Brook downstream of the outfall of one of the wastewater treatment plants investigated.
Credit: Image courtesy of United States Geological Survey

Pharmaceutical manufacturing facilities can be a significant source of pharmaceuticals to surface waters, according to a new study by the U.S. Geological Survey (USGS) conducted in cooperation with the State of New York.

Outflow from two wastewater treatment plants in New York that receive more than 20 percent of their wastewater from pharmaceutical facilities had concentrations of pharmaceuticals that were 10 to 1000 times higher than outflows from 24 plants nationwide that do not receive wastewater from pharmaceutical manufacturers.

"This is the first study in the U.S. to identify pharmaceutical manufacturing facilities as a significant source of pharmaceuticals to the environment," said Matthew C. Larsen, USGS Associate Director for Water. "The USGS is working with water utilities to evaluate alternative water treatment technologies with the goal of reducing the release of pharmaceuticals and other emerging contaminants to the environment."

Maximum concentrations in outflows from the two wastewater treatment plants in New York were:

  • 3,800 parts per billion (ppb) of metaxalone (a muscle relaxant)
  • 1,700 ppb of oxycodone (an opioid prescribed for pain relief)
  • Greater than 400 ppb of methadone (an opioid prescribed for pain relief and drug withdrawal)
  • 160 ppb of butalbital (a barbiturate)
  • Greater than 40 ppb of phendimetrazine (a stimulant prescribed for obesity) and carisoprodol (a muscle relaxant)
  • 3.9 ppb diazepam (an anti-anxiety medication)

While pharmaceutical concentrations were significantly lower in receiving streams, measurable concentrations were detected as far as 20 miles downstream.

By contrast, outflow from the wastewater treatment plants that do not receive wastewater from pharmaceutical manufacturing facilities had concentrations that rarely exceeded one ppb.

"This study would not have been possible without the cooperation and support of the New York Department of Environmental Conservation and wastewater treatment plants in New York and nationwide," said USGS scientist Patrick Phillips, who led the study. "We continue to work with the NYS DEC to monitor the quality of the outflows and receiving streams."

For this study, USGS scientists collected outflow samples periodically from 2004 to 2009 from three New York wastewater treatment plants, two of which receive more than 20 percent of their wastewater from pharmaceutical manufacturing facilities. USGS also collected samples from 2006-2009 from 23 selected wastewater treatment plants across the nation that do not receive wastewater from pharmaceutical manufacturing facilities.

All of the samples were analyzed for seven pharmaceuticals, including opioids and muscle relaxants, representing some of the most frequently prescribed medications in the U.S. Some pharmaceuticals studied have not previously been included in environmental studies.

The pharmaceuticals investigated in this study were identified using a forensic approach that identified initially unknown chemicals present in the wastewater treatment plant outflows at elevated levels. Although public records were not available for all pharmaceuticals formulated at these sites, available data indicate that these seven pharmaceuticals are manufactured at one or both of the New York facilities involved in the study. Additional pharmaceuticals were identified in the outflow of these two wastewater treatment plants, and ongoing studies are documenting the levels at which they occur in the environment.

This study is part of a long-term effort to determine the fate and effects of chemicals of emerging environmental concern and to provide water-resource managers with objective information that assists in the development of effective water management practices. More information can be found online at http://toxics.usgs.gov/highlights/PMFs.html .


Story Source:

The above story is based on materials provided by United States Geological Survey. Note: Materials may be edited for content and length.


Cite This Page:

United States Geological Survey. "Manufacturing facilities release pharmaceuticals to the environment, USGS study finds." ScienceDaily. ScienceDaily, 7 June 2010. <www.sciencedaily.com/releases/2010/06/100607101700.htm>.
United States Geological Survey. (2010, June 7). Manufacturing facilities release pharmaceuticals to the environment, USGS study finds. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2010/06/100607101700.htm
United States Geological Survey. "Manufacturing facilities release pharmaceuticals to the environment, USGS study finds." ScienceDaily. www.sciencedaily.com/releases/2010/06/100607101700.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins